Ascorbic Acid Promotes Plasma Cell Differentiation Through Enhancing TET2/3-Mediated DNA Demethylation
Overview
Cell Biology
Molecular Biology
Affiliations
Plasma cells provide high-affinity antibodies against invading pathogens. Although transcriptional and epigenetic mechanisms have been extensively studied for plasma cell differentiation, how these mechanisms respond to environmental cues remains largely unexplored. In this study, we show that ascorbic acid (vitamin C), an essential nutrient, is able to promote plasma cell differentiation and humoral immune response by enhancing TET2/3-mediated DNA demethylation. Ascorbic acid treatment during B cell activation has persistent effects on later plasma cell differentiation by predisposing germinal center B cells toward the plasma cell lineage. Conversely, ascorbic acid deficiency in vivo blocks plasma cell differentiation and attenuates the humoral immune response following antigen immunization. We further demonstrate that such effects of ascorbic acid on plasma cell differentiation require DNA methylcytosine oxidases TET2 and TET3. Our study thus reveals a previously uncharacterized link between essential nutrients and epigenetic regulation of plasma cell differentiation and humoral immune response.
Crosstalk between metabolic and epigenetic modifications during cell carcinogenesis.
Gao Y, Zhang S, Zhang X, Du Y, Ni T, Hao S iScience. 2024; 27(12):111359.
PMID: 39660050 PMC: 11629229. DOI: 10.1016/j.isci.2024.111359.
Comazzetto S, Cassidy D, DeVilbiss A, Jeffery E, Ottesen B, Reyes A Blood. 2024; 145(1):114-126.
PMID: 39437548 PMC: 11738029. DOI: 10.1182/blood.2024024769.
Ghoneem W, Rahmy H, El-Tanany R Trop Anim Health Prod. 2024; 56(8):326.
PMID: 39361180 PMC: 11449954. DOI: 10.1007/s11250-024-04157-x.
Ascorbic acid alleviates rheumatoid arthritis by inhibiting the production of autoantibodies.
Yin Y, Wu S Cell Commun Signal. 2024; 22(1):373.
PMID: 39049070 PMC: 11267742. DOI: 10.1186/s12964-024-01756-x.
Epigenetic modulators provide a path to understanding disease and therapeutic opportunity.
Honer M, Ferman B, Gray Z, Bondarenko E, Whetstine J Genes Dev. 2024; 38(11-12):473-503.
PMID: 38914477 PMC: 11293403. DOI: 10.1101/gad.351444.123.